March 2024 FDA Recall Potassium Chloride by B. Braun Medical Inc
D-0370-2024 - Lack of assurance of sterility

This Class II drug recall was voluntarily initiated by B. Braun Medical Inc on March 6, 2024 for the product Potassium Chloride. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0370-2024

Reason for Recall
Lack of assurance of sterility: pinholes, within the blue label characters on the EXCEL bag, specifically within the dotted characters on the label, resulting in leaks.
Initiated
03-06-2024
Reported
03-20-2024
Quantity
22,752 bags

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
B. Braun Medical Inc
Nationwide in the USA
Potassium Chloride for Injection Concentrate USP, 500 mEq/250 mL (2 mEq/mL), 250 mL Bag, Rx only, B. Braun Medical Inc., Bethlehem, PA 18018, NDC 0264-1944-20

Batch or Lot Expiration Information

Lot# : J2S007, Exp: 12/31/2024; J3A115, Exp: 01/31/2025.

Affected Packages Involved in this Recall